NYMU Taipei/Part List
From 2007.igem.org
(Difference between revisions)
(→Part List) |
|||
Line 22: | Line 22: | ||
|108 | |108 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |? | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_C0082 BBa_C0082] | |[http://partsregistry.org/Part:BBa_C0082 BBa_C0082] | ||
Line 36: | Line 37: | ||
|12 | |12 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |? | ||
|- | |- | ||
|AU43-C7 | |AU43-C7 | ||
Line 64: | Line 66: | ||
|95 | |95 | ||
|pSB1AK3 | |pSB1AK3 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | |[http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | ||
Line 78: | Line 81: | ||
| | | | ||
| | | | ||
+ | |? | ||
|- | |- | ||
|AV88-C6 | |AV88-C6 | ||
Line 106: | Line 110: | ||
|742 | |742 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_I15017 BBa_I15017] | |[http://partsregistry.org/Part:BBa_I15017 BBa_I15017] | ||
Line 113: | Line 118: | ||
|742 | |742 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_R0077 BBa_R0077] | |[http://partsregistry.org/Part:BBa_R0077 BBa_R0077] | ||
Line 120: | Line 126: | ||
|231 | |231 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |OK | ||
|- | |- | ||
|- | |- | ||
Line 128: | Line 135: | ||
|225 | |225 | ||
|pSB1A2 | |pSB1A2 | ||
+ | |OK | ||
|- | |- | ||
|- | |- | ||
Line 136: | Line 144: | ||
|762 | |762 | ||
|pSB2K3 | |pSB2K3 | ||
+ | |OK | ||
|- | |- | ||
|[http://partsregistry.org/Part:BBa_C0076 BBa_C0076] | |[http://partsregistry.org/Part:BBa_C0076 BBa_C0076] | ||
Line 143: | Line 152: | ||
|702 | |702 | ||
|pSB2K3 | |pSB2K3 | ||
+ | |OK | ||
|- | |- | ||
|} | |} |
Revision as of 09:39, 24 August 2007
Project Description /
Lab Notes /
Part List /
Primer List
Part List
Series | alias | Location | Description | part length | vector (antibotics) | Check |
---|---|---|---|---|---|---|
BBa_R0082 | pOmpC | 1 | Positively regulated, OmpR-controlled promoter | 108 | pSB1A2 | ? |
BBa_C0082 | tar-envZ | 1 | Receptor, tar-envZ | 1491 | pSB2K3 | |
BBa_B0034 | RBS | 1,2,3 | The Elowitz RBS (Ribosome binding site) is the definition of efficiency 1.0 | 12 | pSB1A2 | ? |
AU43-C7 | INS | human insulin | 495 | C | ||
INS_A | 1 | alpha chain of human insulin | 63 | |||
INS_B | 1 | beta chain of human insulin | 90 | |||
BBa_B0014 | D-term | 1,2,3 | Double translation terminator | 95 | pSB1AK3 | OK |
BBa_I14032 | pLacIQ | 2 | Constitutive Promoter, High Transcription | 37 | pSB2K3 | |
OmpRBS | 2 | OmpR binding sites | ? | |||
AV88-C6 | IDE | 2 | insulin degradation enzyme of mouse | 3445 | A | |
AU61-F6 | IGFBP3 | 2 | Insulin-like growth factor binding protein 3 of human | 2488 | C | |
AU50-C7 | IGFBP7 | 2 | Insulin-like growth factor binding protein 7 of human | 1155 | C | |
BBa_I15016 | B0032.ECFP | 16D, plate 1 | his part accepts POPS to produce ECFP under the medium RBS B0032 | 742 | pSB1A2 | OK |
BBa_I15017 | B0032.EYFP | 16F, plate 1 | This part accepts POPS to generate EYFP under the medium strength RBS B0032 | 742 | pSB1A2 | OK |
BBa_R0077 | pCinRHSL, RBS+ | 17L, Plate 1 | 231 | pSB1A2 | OK | |
BBa_R0078 | pCinRHSL | 15D, Plate 1 | 225 | pSB1A2 | OK | |
BBa_C0077 | CinR | 7G, Plate 2 | 762 | pSB2K3 | OK | |
BBa_C0076 | HSL | 7E, Plate 2 | 702 | pSB2K3 | OK |
antibiotics keys
- A: Ampicillin
- K: Kanamycin
- C: Chloramphenicol